109236 ⎘
Production; Biochemical production, i.e. in a transformed host cell Specially adapted vectors
Double-stranded ribonucleic acid as control against insects
#302IN VIVO PRODUCTION OF SMALL INTERFERING RNAS THAT MEDIATE GENE SILENCING
#303Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs
#304Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter
#305Huntington's disease therapeutic compounds
#306Placental like alkaline phosphatase (PLAP) promoter mediated cell targeting
#307Targeting chromatin modifiers for the treatment of medical conditions
#308Methods for including cardiomyocyte proliferation
#309Methods for co-silencing expression of genes in filamentous fungal strains and uses thereof
#310Method and compositions for the genetic control of insect pests in cotton plants by chitin synthase gene silencing
#311Compositions and methods to treat latent viral infections
#312Compositions and methods of delivering treatments for latent viral infections
#313Furin-knockdown bi-functional RNA
#314Recombinant adenovirus with increased safety and anticancer activities, and use thereof
#315Cell capable of producing adeno-associated virus vector
#316Method for establishing modified host cell
#317Synthetic promoter for modulating gene expression
#318Use of monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
#319Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression
#320Methods and compositions for in vivo induction of pancreatic beta cell formation
#321Vector for the selective silencing of a gene in astrocytes
#322Composition comprising miRNA for enhancing radiation sensitivity
#323Trans-acting RNA switches
#324Aptamer modulators of estrogen receptors
#325Methods and compositions involving NKG2D inhibitors and cancer
#326Metabolic gene mesenchymal signatures and uses thereof
#327Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro
#328Culicinae mosquito Tra-2 RNA interference technique to genetically produce maleness population
#329Recombinant virus products and methods for inhibition of expression of DUX4
#330Modified parvovirus useful for gene silencing
#331Reduction of off-target RNA interference toxicity
#332Process for purifying VLPs
#333Replication capable rAAV vectors encoding inhibitory siRNA and methods of their use
#334Construction of bifunctional short hairpin RNA
#335Methods and compositions for reducing amyloid beta levels
#336Optimization of vectors for effective delivery and expression of genetic content
#337Control of gene expression
#338Terminator sequence-containing reverse primer for overexpression and linear DNA
#339Therapeutic compounds
#340Production and extraction of MicroRNA precursor as drug for cancer therapy
#341Compositions and methods for treatment of melanoma
#342Recombinant virus products and methods for inhibition of expression of myotilin
#343Compositions and methods for treating leukemia
#344Production and utilization of a novel anti-cancer drug in therapy
#345Promoters and terminators for use in eukaryotic cells
#346Supercoiled minicircle DNA for gene therapy applications
#347Down-regulating gene expression in insect pests
#348Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL
#349Nucleic acids encoding FOXD3 promoter and methods to isolate FOXD3 expressing cells
#350Adeno-associated virus 2/8—micro RNA-101 therapy for liver cancer
#351Modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy
#352Methods and compositions for malic enzyme 2 (ME2) as a target for cancer therapy
#353Compositions and Methods for the Delivery of Biologically Active RNAs
#354AAV-based treatment of cholesterol-related disorders
#355Therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumors
#356COMPOSITIONS AND METHODS FOR TREATING PROSTATE CANCER
#357SUMO as a marker of cancer development and target for cancer therapy
#358Modified U7 snRNAs for treatment of neuromuscular diseases
#359Nucleic acids for targeting multiple regions of the HCV genome
#360Supercoiled minivectors for gene therapy applications
#361Reduction of off-target RNA interference toxicity
#362CONTROL OF GENE EXPRESSION
#363Identification of RNAI targets and use of RNAI for rational therapy of chemotherapy-resistant leukemia and other cancers
#364Antiangiogenic Agent and Method for Inhibition of Angiogenesis
#365Trans-acting RNA switches
#366IMMUNIZATION STRATEGY TO PREVENT H1N1 INFECTION
#367System for Synergistic Expression of Multiple Small Functional RNA Elements
#368Methods and products for expression of micro RNAs
#369MIRNA INHIBITION OF SIX1 EXPRESSION
#370Construction of bifunctional short hairpin RNA
#371Vector utilizing borna disease virus and use thereof
#372Multi-Cistronic shRNA Expression Cassette for Suppressing Single or Multiple Target Genes
#373Gene vector
#374METHODS AND KITS TO GENERATE miRNA- AND SMALL RNA-EXPRESSING VECTORS, AND ITS APPLICATION TO DEVELOP LENTIVIRAL EXPRESSION LIBRARIES
#375Mesenchymal Stem Cells Producing Inhibitory RNA for Disease Modification
#376Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
#377Cand45 tRNA-Derived Expression System for Gene Modulation
#378Novel Target for Regulating Multiple Sclerosis
#379Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders
#380MULTIPLE RNA POLYMERASE III PROMOTER EXPRESSION CONSTRUCTS
#381MHC-less cells
#382Single-stranded nucleic acid molecule for controlling gene expression
#383METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION
#384MODIFIED snRNAs FOR USE IN THERAPY
#385Treatment of metabolic-related disorders using hypothalamic gene transfer of BDNF and compositions therefor
#386Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator
#387GENE SILENCING
#388In vivo production of small interfering RNAs that mediate gene silencing
#389Compositions and methods for silencing Ebola virus gene expression
#390System For Synergetic Expression Of Multiple Small Functional RNA Elements
#391DNA molecule for expressing Hairpin RNA, the constructing method and the use thereof
#392AGENT FOR PROMOTING NEURONAL DIFFERENTIATION AND METHOD THEREFOR
#393Supercoiled minivectors™ for gene therapy applications
#394Furin-knockdown bi-functional RNA
#395Use on minicircle vectors for cardiac gene therapy
#396Therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumors
#397Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression
#398THERAPEUTIC TARGETS AND MEDICAMENTS INVOLVING P230/GOLGIN-245
#399Nucleic acids encoding SOX10 promoter and methods to isolate SOX10 expressing cells
#400Methods and compositions for regulated expression of multiple nucleic acids
#401Composition of Asymmetric RNA Duplex As MicroRNA Mimetic or Inhibitor
#402METHODS OF GENERATING EXPANDED AND RE-DIFFERENTIATED ADULT ISLET BETA CELLS CAPABLE OF PRODUCING INSULIN
#403TREATMENT AND PREVENTION OF HIV INFECTION
#404Development of universal cancer drugs and vaccines
#405Vivo production of small interfering RNAs that mediate gene silencing
#406In vivo production of small interfering RNAS that mediate gene silencing
#407Genetic control of mammalian cells with synthetic RNA regulatory systems
#408Isolation of novel AAV'S and uses thereof
#409SAFE LENTIVIRAL VECTORS FOR TARGETED DELIVERY OF MULTIPLE THERAPEUTIC MOLECULES
#410METHODS INVOLVING LEF-1 REGULATION AND USE OF LEF-1 OR COMPOUNDS ALTERING LEF-1 SIGNALLING FOR TREATING OR PREVENTING DISEASES
#411Lentiviral vectors allowing RNAi mediated inhibition of GFAP and vimentin expression
#412Olig1 mini-promoters
#413Methods and compositions for reducing amyloid beta levels
#414METHOD FOR CONSTRUCTING MICRORNA ADENOVIRUS EXPRESSION PLASMIDS OF SEVERE HEPATITIS RELATED HFGL2, HFAS AND HTNFR1 GENES AND PHARMACEUTICAL USE THEREOF
#415Multiple RNA polymerase III promoter expression constructs
#416Target for regulating multiple sclerosis
#417pCryptoRNAi
#418Compositions of asymmetric interfering RNA and uses thereof
#419Reduction of off-target RNA interference toxicity
#420In vivo production of small interfering RNAs that mediate gene silencing
#421Control of gene expression
#422In vivo production of small interfering RNAS that mediate gene silencing
#423DNA cassette for cellular expression of small RNA
#424Methods and products for expression of micro RNAs